NBIX
Neurocrine Biosciences Inc. (NBIX)
NASDAQ · Healthcare
Neurocrine Biosciences Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Neurocrine Biosciences Inc. revenue for the quarter ending March 31, 2026 was 814.5 M, a 42.25% increase year-over-year.
- Neurocrine Biosciences Inc. revenue for the twelve months ending March 31, 2026 was 2.9 B, a 28.89% increase year-over-year.
- Neurocrine Biosciences Inc. annual revenue for 2025 was 2.9 B, a 21.45% increase from 2024.
- Neurocrine Biosciences Inc. annual revenue for 2024 was 2.4 B, a 24.81% increase from 2023.
- Neurocrine Biosciences Inc. annual revenue for 2023 was 1.9 B, a 26.76% increase from 2022.
- Neurocrine Biosciences Inc. annual revenue for 2022 was 1.5 B.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Neurocrine Biosciences Inc. Earnings — FAQ
Neurocrine Biosciences Inc. (NBIX) earnings over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NBIX's earnings history?
The chart and table above show Neurocrine Biosciences Inc.'s earnings by year and by quarter, including the growth rate.